Racial Differences Explored in Treatment Response for Hepatitis C
University of North Carolina Health Care SystemThe University of North Carolina at Chapel Hill School of Medicine has been granted $1.5M to join seven other medical centers around the country to determine if African-Americans respond less well to anti-viral drug therapy for hepatitis C infection than Caucasians.